Comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 vs 14q32 Duplication Syndrome C4225449
Clinical comparison between 3 Beta Hydroxysteroid Dehydrogenase Deficiency and 14q32 Duplication Syndrome for differential diagnosis and treatment planning.
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
A rare genetic disorder affecting adrenal hormone production. It can cause ambiguous genitalia, salt-wasting crises, and hormonal imbalances. Treatment requires hormone replacement therapy and careful monitoring.
14q32 Duplication Syndrome C4225449
A rare chromosomal disorder where extra genetic material from chromosome 14 is present. It can affect development and cause intellectual disability, distinctive facial features, and other health issues. Management focuses on addressing symptoms with specialized care.
6 comparison axes
Onset
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
0-null
14q32 Duplication Syndrome C4225449
0-0
Onset patterns differ
Severity
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
severe
14q32 Duplication Syndrome C4225449
moderate
Different severity levels
Chronic
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
Chronic
14q32 Duplication Syndrome C4225449
Chronic
Differing course
Communicable
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
No
14q32 Duplication Syndrome C4225449
No
Different transmission
Body System
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
14q32 Duplication Syndrome C4225449
congenital
Same/different system
Category
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
14q32 Duplication Syndrome C4225449
genetic
Different category
Bottom line
3-beta-hydroxysteroid-dehydrogenase-deficiency-C0342471 and 14q32-duplication-syndrome-C4225449 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 14q32 Duplication Syndrome C4225449 | Discriminating power |
|---|---|---|---|
| Genital or sex-development findings | May include ambiguous genitalia from disordered steroid hormone production. | Not described as a defining feature; developmental and facial findings are emphasized. | Moderate |
| Acute salt-wasting illness | May cause salt-wasting crises and hormonal imbalance, especially in infancy. | Not established from the supplied description. | High |
| Neurodevelopmental pattern | Intellectual disability is not a stated core feature. | May include intellectual disability, developmental effects, and distinctive facial features. | Moderate |
When to favor each condition
Choose 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 when
Infant with suspected adrenal crisis
Salt-wasting and adrenal hormone disruption fit the endocrine disorder better.
High
Abnormal genital development with endocrine clues
The supplied description links ambiguous genitalia to disordered steroid production.
Moderate
Need for hormone replacement planning
Management is described as hormone replacement with careful monitoring.
Moderate
Choose 14q32 Duplication Syndrome C4225449 when
Developmental delay with dysmorphic features
The chromosomal condition is described through developmental and facial findings.
Moderate
Suspected copy-number variant
Extra chromosome 14q32 material is the stated cause.
High
Symptom-focused multidisciplinary care
Management is described as addressing individual health and developmental needs.
Moderate
How key tests differ
| Test | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 14q32 Duplication Syndrome C4225449 | Interpretation |
|---|---|---|---|
| Steroid hormone profile | May show adrenal steroid imbalance; exact cutoffs are not supplied. | No characteristic endocrine pattern is established here. | Abnormal results support endocrine evaluation but do not alone prove the diagnosis. |
| Chromosomal microarray or karyotype | Not expected to identify 14q32 duplication. | May detect extra material from chromosome 14q32. | Genetic confirmation is required; a normal result does not exclude other diagnoses. |
| Electrolytes during illness | May be abnormal during salt-wasting, but thresholds are not established here. | No specific electrolyte pattern is supplied. | Treat urgent abnormalities clinically and interpret with specialist input. |
Prognosis comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
- Outcome
- Chronic and potentially severe, but exact outcomes are not established.
- Factors
- Hormone imbalance, salt-wasting risk, and response to monitored replacement may matter.
14q32 Duplication Syndrome C4225449
- Outcome
- Chronic with generally moderate severity in the supplied classification.
- Factors
- Developmental needs, associated health issues, and available supportive care may influence course.
Time frame: Often lifelong; onset details are incomplete in the source.
Prognosis should be individualized; no mortality or prevalence figures are supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Salt-wasting crisis | A described potential emergency related to adrenal hormone deficiency. Not established in the supplied source. Urgent care is needed for suspected crisis; exact risk is not quantified. |
| Developmental disability | Not described as a defining complication. Intellectual disability and broader developmental effects may occur. Severity and functional impact vary and are not established here. |
| Associated congenital health issues | Mainly hormonal and genital-development concerns are described. Other health issues may accompany the chromosomal duplication. The range of issues is not specified and needs individualized assessment. |
Patient education highlights
- HighEmergency symptoms
Seek urgent care for vomiting, lethargy, dehydration, or suspected salt-wasting in the endocrine condition.
- MediumDifferent causes
One condition involves steroid hormone production; the other involves extra chromosomal material.
- MediumSpecialist follow-up
Endocrine, genetics, and developmental specialists can guide testing, monitoring, and supportive care.